RPTX: Repare Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 191.09
Enterprise Value ($M) 79.82
Book Value ($M) 212.08
Book Value / Share 5.03
Price / Book 0.90
NCAV ($M) 201.87
NCAV / Share 4.79
Price / NCAV 0.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 6.24
Current Ratio 6.24

Balance Sheet (mrq) ($M)
Current Assets 243.69
Assets 253.90
Liabilities 41.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 51.13
Operating Income -116.22
Net Income -93.80

Cash Flow Statement (mra) ($M)
Cash From Operations -127.16
Cash from Investing 78.04
Cash from Financing 0.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Blue Owl Capital Holdings LP 7.41
02-14 13G/A Deep Track Capital, LP 7.10 9.72
02-14 13G/A Redmile Group, LLC 5.10 -19.95
01-29 13G/A ARK Investment Management LLC 6.70 16.21
11-17 13D/A Biotechnology Value Fund L P 24.50 13.57

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 7,898 111,706 7.07
2024-03-26 8,614 128,660 6.70
2024-03-25 8,147 57,887 14.07
2024-03-22 7,192 72,834 9.87

(click for more detail)

Similar Companies
RLYB – Rallybio Corporation ROIV – Roivant Sciences Ltd.
RPRX – Royalty Pharma plc RVMD – Revolution Medicines, Inc.
RXRX – Recursion Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io